Blood cholesterol treatment guideline and influence on clinical practice in China
LIU Miao
HE Yao
Abstract：The American College of Cardiology and the American Heart Association released the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults, and the National Lipid Association released national lipid association recommendations for patient-centered management of dyslipidemia: part 1—full report in 2015, which aroused wide attention at home and abroad. These new guidelines have many updates for the basic ideas and speciifc measures compared with the previous guidelines, including appropriate intensity of statin therapy, no longer achieving the intended target LDL-C levels, and the new pooled cohort equations to estimate 10-year ASCVD risk and so on. How to deal with these new guidelines, and to carry out the prevention and treatment of blood lipid combined with the Chinese national conditions, it's an issue that needs to be taken seriously. This paper will give a brief introduction to the main points of these guidelines, and analyze the inlfuence on clinical practice of lipid control in China.
Keywords：DyslipidemiaGuidelineCholesterolStatinsDrug dose
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 197-200 )